Skip to content

Comparative study of Combination of dexmedetomidine with bupivacaine,lidobupivacaine and ropivacaine

Comparative study of the effects of dexmedetomidine added as adjuvant to bupivacaine,levobupivacaine and ropivacaine in brachial plexus blocks: a prospective randomised triple blind study - BLRBB

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/12/030150
Enrollment
80
Registered
2020-12-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M968- Other intraoperative and postprocedural complications and disorders of musculoskeletal system, not elsewhere classified

Interventions

Intervention1: Dexmedetomidine, bupivacaine,levobupivacaine and ropivacaine: Our study is a 4 arm study, the intervension agents in our study are dexmedetomidine+ bupivacaine 0.5%, dexmedetomidine +

Sponsors

Dr Ramana Reddy MV
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Eighty adult patients of age 18 and 80 yrs of either sex with weight betweeen 50 and 80kg and who were of American Society of Anaesthesiologists (ASA) grade I and II, attending our medical college hospital for surgeries of upper limb between the period 01-1-2021 and 31-08-2021 to be enrolled in this study

Exclusion criteria

Exclusion criteria: Exclusion criteria adapted for our study were patients with known allergy to study drugs, patient refusal of local anaesthetic block, patients suffering from neurological disorders, psychiatric disorders, mental retardation, uncontrolled hypertension and diabetes mellitus, coagulation or bleeding abnormalities,pregnant women and lactating mothers, patients on adrenergic agonist/antagonist medications and infection at the site of the block.

Design outcomes

Primary

MeasureTime frame
The primary outcome variables studied were the differences in the duration of the analgesia and the duration of motor and sensory blockTimepoint: Sensory and motor block blockade was assessed every 2 min intervals for the initial 30 min and at 15 minute intervals till completion of surgery and in the first 24 hours of postoperative period

Secondary

MeasureTime frame
The secondary outcome will be the differences in the duration of onset of the motor and sensory block, fluctuations in haemodynamic variables like heart rate (HR), mean arterial pressure (MAP),respiratory rate( RR) and arterial oxygen saturation (SaO2), total dose of rescue analgesics administered during the 1st 24 hours of post operative period, Ramsay sedation score, surgeon assessment score and patient satisfaction score and any adverse events and drug-related side effects.Timepoint: At every 5 minute intervals after completion of the block till completion of the surgery and at 30 minute intervals thereafter till 1st 24 hours of post operative period

Countries

India

Contacts

Public ContactDr Ramanareddy MV

Gayatri Vidya Parishad Institute of Health Care and Medical Technology

drramanareddymoolagani@gmail.com9908232415

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026